208 related articles for article (PubMed ID: 30793095)
1. Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease.
Hemming ML; Klega KS; Rhoades J; Ha G; Acker KE; Andersen JL; Thai E; Nag A; Thorner AR; Raut CP; George S; Crompton BD
JCO Precis Oncol; 2019; 2019():. PubMed ID: 30793095
[TBL] [Abstract][Full Text] [Related]
2. Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas.
Przybyl J; Spans L; Lum DA; Zhu S; Vennam S; Forgó E; Varma S; Ganjoo K; Hastie T; Bowen R; Debiec-Rychter M; van de Rijn M
JCO Precis Oncol; 2019; 3():. PubMed ID: 32232185
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.
Zhou M; Bui N; Rathore R; Sudhaman S; George GV; Malashevich AK; Malhotra M; Liu MC; Aleshin A; Ganjoo KN
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612153
[No Abstract] [Full Text] [Related]
4. Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma.
Madanat-Harjuoja LM; Klega K; Lu Y; Shulman DS; Thorner AR; Nag A; Tap WD; Reinke DK; Diller L; Ballman KV; George S; Crompton BD
Clin Cancer Res; 2022 Jun; 28(12):2579-2586. PubMed ID: 35561344
[TBL] [Abstract][Full Text] [Related]
5. Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma.
Sato T; Montazeri K; Gragoudas ES; Lane AM; Aronow MB; Cohen JV; Boland GM; Banks E; Kachulis C; Fleharty M; Cibulskis C; Lawless A; Adalsteinsson VA; Sullivan RJ; Kim IK
JCO Precis Oncol; 2024 Jan; 8():e2300368. PubMed ID: 38237100
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment.
Sogbe M; Bilbao I; Marchese FP; Zazpe J; De Vito A; Pozuelo M; D'Avola D; Iñarrairaegui M; Berasain C; Arechederra M; Argemi J; Sangro B
Clin Mol Hepatol; 2024 Apr; 30(2):177-190. PubMed ID: 38163441
[TBL] [Abstract][Full Text] [Related]
7. Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma.
Przybyl J; Chabon JJ; Spans L; Ganjoo KN; Vennam S; Newman AM; Forgó E; Varma S; Zhu S; Debiec-Rychter M; Alizadeh AA; Diehn M; van de Rijn M
Clin Cancer Res; 2018 Jun; 24(11):2688-2699. PubMed ID: 29463554
[No Abstract] [Full Text] [Related]
8. Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial.
Sabatier R; Garnier S; Guille A; Carbuccia N; Pakradouni J; Adelaide J; Provansal M; Cappiello M; Rousseau F; Chaffanet M; Birnbaum D; Mamessier E; Gonçalves A; Bertucci F
Front Oncol; 2022; 12():946257. PubMed ID: 35965534
[TBL] [Abstract][Full Text] [Related]
9. Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors.
Klega K; Imamovic-Tuco A; Ha G; Clapp AN; Meyer S; Ward A; Clinton C; Nag A; Van Allen E; Mullen E; DuBois SG; Janeway K; Meyerson M; Thorner AR; Crompton BD
JCO Precis Oncol; 2018; 2018():. PubMed ID: 30027144
[TBL] [Abstract][Full Text] [Related]
10. Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas.
Braig D; Runkel A; Eisenhardt AE; Schmid A; Zeller J; Pauli T; Lausch U; Wehrle J; Bronsert P; Jung M; Kiefer J; Boerries M; Eisenhardt SU
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142126
[TBL] [Abstract][Full Text] [Related]
11. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma.
Nordentoft I; Lindskrog SV; Birkenkamp-Demtröder K; Gonzalez S; Kuzman M; Levatic J; Glavas D; Ptashkin R; Smadbeck J; Afterman D; Lauterman T; Cohen Y; Donenhirsh Z; Tavassoly I; Alon U; Frydendahl A; Rasmussen MH; Andersen CL; Lamy P; Knudsen M; Polak P; Zviran A; Oklander B; Agerbæk M; Jensen JB; Dyrskjøt L
Eur Urol; 2024 May; ():. PubMed ID: 38811314
[TBL] [Abstract][Full Text] [Related]
13. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
14. Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes.
Demoret B; Gregg J; Liebner DA; Tinoco G; Lenobel S; Chen JL
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766329
[TBL] [Abstract][Full Text] [Related]
15. Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors.
Christodoulou E; Yellapantula V; O'Halloran K; Xu L; Berry JL; Cotter JA; Zdanowicz A; Mascarenhas L; Amatruda JF; Ostrow D; Bootwalla M; Gai X; Navid F; Biegel JA
NPJ Precis Oncol; 2023 Feb; 7(1):21. PubMed ID: 36805676
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
[TBL] [Abstract][Full Text] [Related]
17. Somatic Copy Number Alteration in Circulating Tumor DNA for Monitoring of Pediatric Patients with Cancer.
Ruas JS; Silva FLT; Euzébio MF; Biazon TO; Daiggi CMM; Nava D; Franco MT; Cardinalli IA; Cassone AE; Pereira LH; Seidinger AL; Maschietto M; Jotta PY
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189699
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy.
Ono A; Fujimoto A; Yamamoto Y; Akamatsu S; Hiraga N; Imamura M; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Furuta M; Tsunoda T; Miyano S; Kubo M; Aikata H; Ochi H; Kawakami YI; Arihiro K; Ohdan H; Nakagawa H; Chayama K
Cell Mol Gastroenterol Hepatol; 2015 Sep; 1(5):516-534. PubMed ID: 28210698
[TBL] [Abstract][Full Text] [Related]
19. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995
[TBL] [Abstract][Full Text] [Related]
20. Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.
Ortolan E; Appierto V; Silvestri M; Miceli R; Veneroni S; Folli S; Pruneri G; Vingiani A; Belfiore A; Cappelletti V; Vismara M; Dell'Angelo F; De Cecco L; Bianchi GV; de Braud FG; Daidone MG; Di Cosimo S
ESMO Open; 2021 Apr; 6(2):100086. PubMed ID: 33743331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
